Evidence map›Paper›PMID 27901112›Full record

ArticleScientific reports2016

Depletion of tRNA-halves enables effective small RNA sequencing of low-input murine serum samples.

Alan Van Goethem, Nurten Yigit, Celine Everaert, Myrthala Moreno-Smith, Liselot M Mus, Eveline Barbieri, Frank Speleman, Pieter Mestdagh, Jason Shohet, Tom Van Maerken and 1 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.2field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 2 countries.

Alan Van GoethemCenter for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
Nurten YigitCenter for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
Celine EveraertCenter for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
Myrthala Moreno-SmithDepartment of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, United States.
Liselot M MusCenter for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
Eveline BarbieriDepartment of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, United States.
Frank SpelemanCenter for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
Pieter MestdaghCenter for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
Jason ShohetDepartment of Pediatrics, Section of Hematology-Oncology, Texas Children's Cancer Center, Baylor College of Medicine, Houston, Texas, United States.
Tom Van MaerkenCenter for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
Jo VandesompeleCenter for Medical Genetics Ghent (CMGG), Ghent University, Ghent, Belgium.
Ghent University · BEBaylor College of Medicine · USCancer Research Institute Ghent · BEGhent University Hospital · BEChildren's Cancer Center · US

Funding

Targeting the G-CSF/STAT3 signaling pathway in neuroblastoma cancer stem cellsR01CA174808 · NCI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SHOHET, JASON M · 2014 to 2018
$1.7M
NCI NIH HHS R01 CA174808
6 · The paper itself

Abstract

The ongoing ascent of sequencing technologies has enabled researchers to gain unprecedented insights into the RNA content of biological samples. MiRNAs, a class of small non-coding RNAs, play a pivotal role in regulating gene expression. The discovery that miRNAs are stably present in circulation has spiked interest in their potential use as minimally-invasive biomarkers. However, sequencing of blood-derived samples (serum, plasma) is challenging due to the often low RNA concentration, poor RNA quality and the presence of highly abundant RNAs that dominate sequencing libraries. In murine serum for example, the high abundance of tRNA-derived small RNAs called 5' tRNA halves hampers the detection of other small RNAs, like miRNAs. We therefore evaluated two complementary approaches for targeted depletion of 5' tRNA halves in murine serum samples. Using a protocol based on biotinylated DNA probes and streptavidin coated magnetic beads we were able to selectively deplete 95% of the targeted 5' tRNA half molecules. This allowed an unbiased enrichment of the miRNA fraction resulting in a 6-fold increase of mapped miRNA reads and 60% more unique miRNAs detected. Moreover, when comparing miRNA levels in tumor-carrying versus tumor-free mice, we observed a three-fold increase in differentially expressed miRNAs.

Indexed as

AnimalsBiomarkers, TumorFemaleGene ExpressionHigh-Throughput Nucleotide SequencingMaleMiceMicroRNAsNeoplasmsRNA, TransferSequence Analysis, RNASerumBiomarkers, TumorMicroRNAsRNA, Transfer

Identifiers

PMID27901112
PMCPMC5129013
OpenAlexW2559209686

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.